These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 14744774)
21. Peptides derived from the histidine-proline domain of the histidine-proline-rich glycoprotein bind to tropomyosin and have antiangiogenic and antitumor activities. Doñate F; Juarez JC; Guan X; Shipulina NV; Plunkett ML; Tel-Tsur Z; Shaw DE; Morgan WT; Mazar AP Cancer Res; 2004 Aug; 64(16):5812-7. PubMed ID: 15313924 [TBL] [Abstract][Full Text] [Related]
22. Anti-invasive activity of torilin, a sesquiterpene compound isolated from Torilis japonica. Kim MS; Baek JH; Park MT; Sohn TK; Kim SE; Lee JJ; Kim KW Oncol Rep; 2001; 8(2):359-64. PubMed ID: 11182056 [TBL] [Abstract][Full Text] [Related]
23. Canstatin-N fragment inhibits in vitro endothelial cell proliferation and suppresses in vivo tumor growth. He GA; Luo JX; Zhang TY; Wang FY; Li RF Biochem Biophys Res Commun; 2003 Dec; 312(3):801-5. PubMed ID: 14680836 [TBL] [Abstract][Full Text] [Related]
24. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors. Hagedorn M; Zilberberg L; Wilting J; Canron X; Carrabba G; Giussani C; Pluderi M; Bello L; Bikfalvi A Cancer Res; 2002 Dec; 62(23):6884-90. PubMed ID: 12460903 [TBL] [Abstract][Full Text] [Related]
25. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells. Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341 [TBL] [Abstract][Full Text] [Related]
26. p22 is a novel plasminogen fragment with antiangiogenic activity. Kwon M; Yoon CS; Fitzpatrick S; Kassam G; Graham KS; Young MK; Waisman DM Biochemistry; 2001 Nov; 40(44):13246-53. PubMed ID: 11683633 [TBL] [Abstract][Full Text] [Related]
27. Laminin binding to the calreticulin fragment vasostatin regulates endothelial cell function. Yao L; Pike SE; Tosato G J Leukoc Biol; 2002 Jan; 71(1):47-53. PubMed ID: 11781379 [TBL] [Abstract][Full Text] [Related]
28. Endothelial cell surface ATP synthase-triggered caspase-apoptotic pathway is essential for k1-5-induced antiangiogenesis. Veitonmäki N; Cao R; Wu LH; Moser TL; Li B; Pizzo SV; Zhivotovsky B; Cao Y Cancer Res; 2004 May; 64(10):3679-86. PubMed ID: 15150128 [TBL] [Abstract][Full Text] [Related]
29. Evidence of antiangiogenic and antimetastatic activities of the recombinant disintegrin domain of metargidin. Trochon-Joseph V; Martel-Renoir D; Mir LM; Thomaïdis A; Opolon P; Connault E; Li H; Grenet C; Fauvel-Lafève F; Soria J; Legrand C; Soria C; Perricaudet M; Lu H Cancer Res; 2004 Mar; 64(6):2062-9. PubMed ID: 15026344 [TBL] [Abstract][Full Text] [Related]
30. Decorin suppresses tumor cell-mediated angiogenesis. Grant DS; Yenisey C; Rose RW; Tootell M; Santra M; Iozzo RV Oncogene; 2002 Jul; 21(31):4765-77. PubMed ID: 12101415 [TBL] [Abstract][Full Text] [Related]
31. Thrombospondin-1 type 1 repeat recombinant proteins inhibit tumor growth through transforming growth factor-beta-dependent and -independent mechanisms. Miao WM; Seng WL; Duquette M; Lawler P; Laus C; Lawler J Cancer Res; 2001 Nov; 61(21):7830-9. PubMed ID: 11691800 [TBL] [Abstract][Full Text] [Related]
32. gamma-Hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor. Basaki Y; Chikahisa L; Aoyagi K; Miyadera K; Yonekura K; Hashimoto A; Okabe S; Wierzba K; Yamada Y Angiogenesis; 2001; 4(3):163-73. PubMed ID: 11911014 [TBL] [Abstract][Full Text] [Related]
33. Recombinant human prothrombin kringles have potent anti-angiogenic activities and inhibit Lewis lung carcinoma tumor growth and metastases. Kim TH; Kim E; Yoon D; Kim J; Rhim TY; Kim SS Angiogenesis; 2002; 5(3):191-201. PubMed ID: 12831060 [TBL] [Abstract][Full Text] [Related]
34. Mycophenolate mofetil inhibits tumor growth and angiogenesis in vitro but has variable antitumor effects in vivo, possibly related to bioavailability. Koehl GE; Wagner F; Stoeltzing O; Lang SA; Steinbauer M; Schlitt HJ; Geissler EK Transplantation; 2007 Mar; 83(5):607-14. PubMed ID: 17353782 [TBL] [Abstract][Full Text] [Related]
35. Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice. Reinmuth N; Liu W; Ahmad SA; Fan F; Stoeltzing O; Parikh AA; Bucana CD; Gallick GE; Nickols MA; Westlin WF; Ellis LM Cancer Res; 2003 May; 63(9):2079-87. PubMed ID: 12727823 [TBL] [Abstract][Full Text] [Related]
36. Endostatin-induced modulation of plasminogen activation with concomitant loss of focal adhesions and actin stress fibers in cultured human endothelial cells. Wickström SA; Veikkola T; Rehn M; Pihlajaniemi T; Alitalo K; Keski-Oja J Cancer Res; 2001 Sep; 61(17):6511-6. PubMed ID: 11522648 [TBL] [Abstract][Full Text] [Related]
37. Generation of multiple angiogenesis inhibitors by human pancreatic cancer. Kisker O; Onizuka S; Banyard J; Komiyama T; Becker CM; Achilles EG; Barnes CM; O'Reilly MS; Folkman J; Pirie-Shepherd SR Cancer Res; 2001 Oct; 61(19):7298-304. PubMed ID: 11585769 [TBL] [Abstract][Full Text] [Related]
38. Deguelin inhibits vasculogenic function of endothelial progenitor cells in tumor progression and metastasis via suppression of focal adhesion. Nguyen MP; Lee D; Lee SH; Lee HE; Lee HY; Lee YM Oncotarget; 2015 Jun; 6(18):16588-600. PubMed ID: 26078334 [TBL] [Abstract][Full Text] [Related]
39. Angiostatin: an endogenous inhibitor of angiogenesis and of tumor growth. O'Reilly MS EXS; 1997; 79():273-94. PubMed ID: 9002223 [TBL] [Abstract][Full Text] [Related]
40. Plasmin-cleaved beta-2-glycoprotein 1 is an inhibitor of angiogenesis. Sakai T; Balasubramanian K; Maiti S; Halder JB; Schroit AJ Am J Pathol; 2007 Nov; 171(5):1659-69. PubMed ID: 17872974 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]